ciglitazone has been researched along with Empyema, Gall Bladder in 1 studies
ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.
Excerpt | Relevance | Reference |
---|---|---|
" Ciglitazone inhibits the inflammation of HGBECs in vitro and has potential therapeutic effect on cholecystitis in vivo." | 3.73 | Effect of peroxisome proliferator-activated receptor-gamma ligand on inflammation of human gallbladder epithelial cells. ( Cheng, NS; Li, SF; Liu, JW; Pan, GD; Wu, H; Xiong, XZ; Yan, LN; Zhang, GF, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pan, GD | 1 |
Wu, H | 1 |
Liu, JW | 1 |
Cheng, NS | 1 |
Xiong, XZ | 1 |
Li, SF | 1 |
Zhang, GF | 1 |
Yan, LN | 1 |
1 other study available for ciglitazone and Empyema, Gall Bladder
Article | Year |
---|---|
Effect of peroxisome proliferator-activated receptor-gamma ligand on inflammation of human gallbladder epithelial cells.
Topics: Cells, Cultured; Cholecystitis; Epidermal Growth Factor; Epithelial Cells; Gallbladder; Humans; Infl | 2005 |